Guess which 2 ASX small-cap shares just rocketed 50%+ on big news!

Investors are sending these two ASX small-cap stocks through the roof on Tuesday.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Two ASX small-cap shares are shooting the lights out today, both posting intraday gains of more than 50%.

One is a healthcare technology and services company.

The other is a mineral exploration company.

Which high-flying ASX small-cap shares are we talking about?

I'm glad you asked!

Two kids in superhero capes.

Image source: Getty Images

ASX small-cap share rockets on new contract win

Turning to the healthcare technology and services company first, we have Resonance Health Ltd (ASX: RHT).

Resonance Health shares exited a trading halt at 3.8 cents apiece this morning, and investors sent the ASX small-cap share soaring to 6.2 cents, up 63%. After some likely profit-taking, shares are currently changing hands for 5.6 cents each, up 47%.

Investors have been piling into the healthcare stock after the company announced it has been contracted by Sun Pharmaceutical Industries to be the local Australian sponsor and to provide a range of services for its clinical trial of a new drug compound in Australia.

Sun Pharmaceuticals is a listed international pharmaceutical company with global operations.

The clinical trial agreement is worth an estimated $13.8 million in revenue for Resonance Health over the next two years.

Commenting on the agreement sending the ASX small-cap share rocketing today, Resonance Health CEO Andrew Harrison said:

The agreement is a direct result of the incredible work the team have done in executing the existing clinical trial with the customer and more broadly the company's focus on winning more work in the global clinical trials ecosystem.

This illustrates our ability to win repeat work from customers, and our capacity to scale the size of contract wins.

Also shooting higher today

The second ASX small-cap share that's going ballistic today is resource explorer Petratherm Ltd (ASX: PTR).

Shares in the junior explorer entered a trading halt last Friday after closing last Thursday at 4.9 cents each. In earlier trade, investors sent the stock rocketing to 9.4 cents, up 91.8%. Again, after some likely profit-taking, shares have retraced a touch since then, currently changing hands for 8.1 cents each, up 65.3%.

Petratherm shares are soaring today after the company reported on "outstanding results" with its trial heavy mineral separation test.

According to the release, samples taken from historical drilling at the Rosewood prospect returned "highly significant" heavy mineral grades and mineralogy.

Rosewood is part of Petratherm's Muckanippie project, located in South Australia.

The explorer said that composite samples from wide spaced drill holes over 2.5 kilometres returned heavy mineral concentrations of 12.0% and 12.5 % from shallow depths, with laboratory analysis confirming high titanium mineral content.

Titanium is on the critical minerals list for Australia, the United States and the European Union.

Commenting on the results sending the ASX small-cap share flying higher today, Petratherm CEO Peter Reid said:

The initial metallurgical results from historic drilling at the Rosewood prospect are outstanding and beyond our expectations.

As the Muckanippie project evolves, it continues to surprise with emerging potential to be a significant source of high value titanium minerals and transformational for the company.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Resonance Health. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

a man raises his fists to the air in joyous celebration while learning some exciting good news via his computer screen in an office setting.
Small Cap Shares

Why Bell Potter says this small-cap ASX stock could rise 140%

Let's see what Bell Potter is saying about this stock.

Read more »

Two health workers taking a break.
Small Cap Shares

Down 26% year to date, is it time to buy low on this ASX small-cap?

This exciting ASX small-cap is one to watch.

Read more »

Miner and company person analysing results of a mining company.
Small Cap Shares

This must-watch small cap is up 50% YTD – can it continue?

This small-cap has been rocketing higher in 2026.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Small Cap Shares

Morgans gives its verdict on these small-cap ASX shares

Let's see if the broker is bullish on these shares that are flying under the radar.

Read more »

A railway worker walks along the train tracks in a visi vest and speaking into a walkie talkie.
Small Cap Shares

While the market worried about war and AI, these 2 ASX small caps kept climbing

Big returns do not always come from the loudest stories on the ASX.

Read more »

Children skipping and jumping up a hill.
Small Cap Shares

2 ASX small-cap stocks tipped to double in the next year

These companies could rise as much as 166%.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Small Cap Shares

2 ASX shares that could rise 100% according to Bell Potter

These high-risk, high-reward shares are being recommended by the broker.

Read more »